3 terminated, 1 completed, 1 not yet recruiting. 4 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 2, Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow carbogen: new trials by email Literature Review of carbogen trials Research Report on carbogen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CompARing Between CO2 Phenylephrine and Phenylephrine Only Treatment in Patients With proGrEssing Cerebral infarctioN carbogen with or without phenyleprhine, phenylephrine - Acute Ischemic Stroke | Phase 3 | Not yet recruiting | Yonsei University | 40 | 2025-02-01 | 2025-01-20 |
| Comparing Between CO2 and Phenylephrine Treatment in Patients With Progressive Lacunar Infarction (CARBOGEN Study) carbogen, phenylephrine - Acute Ischemic Stroke | Phase 3 | Terminated | Yonsei University | 3 | 2021-04-05 | 2025-01-14 |
| Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures Carbogen, Placebo - Febrile Seizure | Phase 2 / Phase 3 | Terminated | Charite University, Berlin, Germany | 96 | 2012-08-01 | 2018-01-26 |
| Imaging and Biomarkers of Hypoxia in Solid Tumors PET Scan, EF5, Carbogen - Neoplasms | Phase 1 | Terminated | Stanford University | 28 | 2010-12-01 | 2017-11-06 |
| Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer niacinamide, carbogen, radiation therapy - Bladder Cancer | Phase 3 | Completed | Mount Vernon Cancer Centre at Mount Vernon Hospital | 330 | 2000-10-01 | 2013-09-20 |
Ischemic Stroke (2) · Stroke, Lacunar (2) · Alkalosis, Respiratory (1) · Neoplasms (1) · Seizures, Febrile (1) · Urinary Bladder Neoplasms (1)
Yonsei University (2) · Charite University, Berlin, Germany (1) · Mount Vernon Cancer Centre at Mount Vernon Hospital (1) · Stanford University (1)
South Korea (2) · Germany (1) · United Kingdom (1) · United States (1)
Hyo Suk Nam, MD, PhD (1) · Peter J. Hoskin, MD (1)